hydroxyproline has been researched along with Cardiovascular Stroke in 95 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Empagliflozin administered early after myocardial infarction reduce myocardial fibrosis and inhibit the TGF-β1/Smad3 fibrotic pathway, probably prior to exerting any hemodynamic or physiological effect." | 8.02 | The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats. ( Atar, S; Bandel, N; Daud, E; Ertracht, O; Moady, G; Reuveni, T; Shehadeh, M, 2021) |
| "Our objective was to analyze the effect of spironolactone on cardiac remodeling after experimental myocardial infarction (MI), assessed by matricellular proteins levels, cardiac collagen amount and distribution, myocardial tissue metalloproteinase inhibitor-1 (TIMP-1) concentration, myocyte hypertrophy, left ventricular architecture, and in vitro and in vivo cardiac function." | 7.79 | Mechanisms involved in the beneficial effects of spironolactone after myocardial infarction. ( Azevedo, PS; Chiuso-Minicucci, F; dos Santos, PP; Gonçalves, AF; Minicucci, MF; Okoshi, K; Paiva, SA; Pereira, EJ; Polegato, BF; Rafacho, BP; Silva, RA; Zornoff, LA, 2013) |
| " Thus, we evaluated the effects of atorvastatin on cardiac function, remodeling, fibrosis, and apoptosis after myocardial infarction (MI)." | 7.77 | Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction. ( Bi, Q; Bolli, R; Dawn, B; Hunt, G; Peng, Y; Sanganalmath, SK; Sato, H; Shirk, G; Tang, XL; Vincent, RJ, 2011) |
| "To investigate the effects of carvedilol and metoprolol on cardiac fibrosis in rats with experimental myocardial infarction (MI)." | 7.74 | [Effects of carvedilol and metoprolol on cardiac fibrosis in rats with experimental myocardial infarction]. ( Chen, H; Guo, CY; Li, HW; Li, ZZ; Shen, LH; Sun, T; Tang, CS, 2008) |
| "Although thalidomide had no effect on cardiac function, our results suggest that intervention with thalidomide may have beneficial effects in post-MI HF by attenuating collagen accumulation and development of myocardial fibrosis." | 7.73 | Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats. ( Attramadal, H; Aukrust, P; Bjørnerheim, R; Frøland, SS; Oie, E; Ueland, T; Vinge, LE; Wang, JE; Yndestad, A, 2006) |
| "Canrenone attenuates LV interstitial remodeling and reduces filling pressures in rats with postinfarction heart failure." | 7.71 | Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure. ( Casaburi, C; Cittadini, A; Di Gianni, A; Monti, MG; Saccà, L; Saldamarco, L; Scherillo, G; Serpico, R; Vanasia, M, 2002) |
| "We sought to determine whether reperfusion and the calcium channel blocker amlodipine or the angiotensin-converting enzyme inhibitor enalapril, during healing over six weeks after myocardial infarction (MI), limit structural vascular remodeling in the noninfarct zone (NIZ)." | 7.71 | Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril. ( Idikio, H; Jugdutt, BI; Kumar, D; Menon, V, 2002) |
| "We investigated the effect of indomethacin, a widely used nonsteroidal antiinflammatory drug, on the healing of myocardial infarction (MI)." | 7.66 | Indomethacin-induced scar thinning after experimental myocardial infarction. ( Braunwald, E; Brown, EJ; Hale, S; Hammerman, H; Kloner, RA; Schoen, FJ, 1983) |
| "Empagliflozin administered early after myocardial infarction reduce myocardial fibrosis and inhibit the TGF-β1/Smad3 fibrotic pathway, probably prior to exerting any hemodynamic or physiological effect." | 4.02 | The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats. ( Atar, S; Bandel, N; Daud, E; Ertracht, O; Moady, G; Reuveni, T; Shehadeh, M, 2021) |
| " Isoproterenol (ISO)-induced cardiotoxicity challenged mice were treated with NY for 28 days at two doses (0." | 3.88 | Nanoyttria attenuates isoproterenol-induced cardiac injury. ( Godugu, C; Khurana, A; Kumari, P, 2018) |
| "Our objective was to analyze the effect of spironolactone on cardiac remodeling after experimental myocardial infarction (MI), assessed by matricellular proteins levels, cardiac collagen amount and distribution, myocardial tissue metalloproteinase inhibitor-1 (TIMP-1) concentration, myocyte hypertrophy, left ventricular architecture, and in vitro and in vivo cardiac function." | 3.79 | Mechanisms involved in the beneficial effects of spironolactone after myocardial infarction. ( Azevedo, PS; Chiuso-Minicucci, F; dos Santos, PP; Gonçalves, AF; Minicucci, MF; Okoshi, K; Paiva, SA; Pereira, EJ; Polegato, BF; Rafacho, BP; Silva, RA; Zornoff, LA, 2013) |
| " Thus, we evaluated the effects of atorvastatin on cardiac function, remodeling, fibrosis, and apoptosis after myocardial infarction (MI)." | 3.77 | Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction. ( Bi, Q; Bolli, R; Dawn, B; Hunt, G; Peng, Y; Sanganalmath, SK; Sato, H; Shirk, G; Tang, XL; Vincent, RJ, 2011) |
| "To investigate the effects of carvedilol and metoprolol on cardiac fibrosis in rats with experimental myocardial infarction (MI)." | 3.74 | [Effects of carvedilol and metoprolol on cardiac fibrosis in rats with experimental myocardial infarction]. ( Chen, H; Guo, CY; Li, HW; Li, ZZ; Shen, LH; Sun, T; Tang, CS, 2008) |
| "To determine whether therapy with the angiotensin II type 1 receptor blocker (ARB) candesartan and the comparator angiotensin-converting-enzyme inhibitor (ACEI) enalapril during healing after reperfused ST-elevation myocardial infarction (RSTEMI) limit adverse remodeling of infarct zone (IZ) collagens and left ventricular (LV) diastolic dysfunction, we randomized 24 dogs surviving anterior RSTEMI (90-min coronary occlusion) to placebo, candesartan, and enalapril therapy between day 2 and 42." | 3.74 | Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction. ( Idikio, H; Jugdutt, BI; Uwiera, RR, 2007) |
| "Although thalidomide had no effect on cardiac function, our results suggest that intervention with thalidomide may have beneficial effects in post-MI HF by attenuating collagen accumulation and development of myocardial fibrosis." | 3.73 | Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats. ( Attramadal, H; Aukrust, P; Bjørnerheim, R; Frøland, SS; Oie, E; Ueland, T; Vinge, LE; Wang, JE; Yndestad, A, 2006) |
| "Canrenone attenuates LV interstitial remodeling and reduces filling pressures in rats with postinfarction heart failure." | 3.71 | Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure. ( Casaburi, C; Cittadini, A; Di Gianni, A; Monti, MG; Saccà, L; Saldamarco, L; Scherillo, G; Serpico, R; Vanasia, M, 2002) |
| "We sought to determine whether reperfusion and the calcium channel blocker amlodipine or the angiotensin-converting enzyme inhibitor enalapril, during healing over six weeks after myocardial infarction (MI), limit structural vascular remodeling in the noninfarct zone (NIZ)." | 3.71 | Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril. ( Idikio, H; Jugdutt, BI; Kumar, D; Menon, V, 2002) |
| "We sought to compare the effects of two different beta-blockers, carvedilol and metoprolol, to an angiotensin-converting enzyme (ACE) inhibitor (captopril) on myocardial collagen deposition during healing and ventricular remodeling after myocardial infarction (MI)." | 3.70 | Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction. ( Chow, LT; Sanderson, JE; Wei, S, 2000) |
| " This study aimed to analyze the effects of lisinopril on mortality rate, cardiac function, degree of cardiac hypertrophy and fibrosis in rats with different infarct sizes." | 3.70 | Effects of lisinopril on experimental ischemia in rats. Influence of infarct size. ( Matsubara, BB; Matsubara, LS; Paiva, SA; Spadaro, J; Tornero, MT; Zornoff, LA, 1999) |
| "To evaluate the effects of losartan on ventricular remodeling and on survival after myocardial infarction in rats." | 3.70 | Effects of losartan on ventricular remodeling in experimental infarction in rats. ( Matsubara, BB; Matsubara, LS; Paiva, SA; Spadaro, J; Zornoff, LA, 2000) |
| "Myocyte morphometrics (isolated cell technique) and collagen content (hydroxyproline analysis) were assessed 28 days following experimental myocardial infarction from rats with permanently ligated left coronary vessels (NRP; n = 10) compared with rats who underwent reperfusion 150 minutes after ligation (RP; n = 11) and a sham-operated group (n = 10)." | 3.69 | The effect of delayed reperfusion following infarction in the rat on structural changes in viable myocardium. ( Carlyle, W; Chu, C; Francis, G; Hartman, M; Hauer, K; Judd, D; McDonald, K; Toher, C, 1997) |
| "To assess whether the reduction in ischaemic injury during acute myocardial infarction induced by nitroglycerin (NTG) results in a decrease in tissue necrosis, 96 rats were assigned to two groups." | 3.67 | Long-term protection of ischaemic myocardium by nitroglycerin ointment. ( Ambrosio, G; Brevetti, G; Cataffo, A; Chiariello, M; Condorelli, M; Pollice, U, 1984) |
| "A total of 136 patients with trans- and 200 with non-transmural myocardial infarction (MI) were examined over time for chlorine-soluble mucoprotein (MP), serum hexoses (SH), their fraction-hexoses of glycosaminoglycans (H-GAG), and hexoses of glycoproteins (H-GP), serum, plasma and urine hydroxyproline (SHP, PHP, UHP)." | 3.67 | [Clinical regularities of myocardial infarction repair]. ( Kaliabin, GA; Movshovich, BL, 1989) |
| "The healing process of myocardial infarction was studied with special reference to the production of collagen by the determinations of prolylhydroxylase (PHase) activity and contents of hydroxyproline (Hyp) of the collagen subfractions, i." | 3.67 | Studies on collagen in the experimental myocardial infarction. ( Katagiri, T; Sasai, Y; Sekita, S; Takeda, K, 1985) |
| "We investigated the effect of indomethacin, a widely used nonsteroidal antiinflammatory drug, on the healing of myocardial infarction (MI)." | 3.66 | Indomethacin-induced scar thinning after experimental myocardial infarction. ( Braunwald, E; Brown, EJ; Hale, S; Hammerman, H; Kloner, RA; Schoen, FJ, 1983) |
| "Mature male Sprague-Dawley rats were subjected to an isoproterenol-induced myocardial infarction." | 3.65 | Prolyl hydroxylase and collagen metabolism after experimental mycardial infarction. ( Judd, JT; Wexler, BC, 1975) |
| "A rat model of ventricular remodeling after myocardial infarction was established by left coronary artery ligation." | 1.42 | Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats. ( Chen, C; Gao, J; Gao, Y; Guo, J; Wang, H; Wu, R, 2015) |
| "Endothelial dysfunction can lead to congestive heart failure and the activation of endothelial ATP-sensitive potassium (K(ATP)) channels may contribute to endothelial protection." | 1.40 | Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy. ( Cui, WY; Long, CL; Wang, H; Zhang, YF; Zhong, ML; Zhou, HM, 2014) |
| "EERS attenuates ventricular remodeling." | 1.38 | Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats. ( Chen, CX; Huang, XY; Li, YM; Liu, Y; Wu, XM; Zhang, XM, 2012) |
| "The experimental ventricular remodeling was induced with ligating the left anterior descending branch of the coronary artery of the rats." | 1.36 | Effects of Chinese herb medicine Radix Scrophulariae on ventricular remodeling. ( Chen, CX; Gu, WL; Liu, Y; Lü, J; Wu, Q; Zhang, SJ, 2010) |
| "Ramipril treatment caused an increase in catalase, glutathione peroxidase, and SOD activity in the LV tissue." | 1.35 | A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit. ( Chao, CL; Chen, CY; Chen, MF; Ho, YL; Hsu, HC; Lee, BC; Lin, HJ; Lin, YH, 2008) |
| "Cells isolated from the heart scar were identified as myofibroblasts." | 1.35 | Regulatory influence of melatonin on collagen accumulation in the infarcted heart scar. ( Dabrowski, R; Drobnik, J; Jakubowski, L; Karbownik-Lewińska, M; Olczak, S; Szczepanowska, A; Słotwińska, D, 2008) |
| "Left ventricular remodeling and function were followed for 12 weeks post-MI." | 1.32 | Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice. ( Cavasin, MA; Menon, S; Tao, Z; Yang, XP, 2004) |
| "Scarring is markedly reduced in MRL mice compared with C57BL/6 mice, consistent with both the reduced hydroxyproline levels seen after injury and an elevated cardiomyocyte mitotic index of 10-20% for the MRL compared with 1-3% for the C57BL/6." | 1.31 | Heart regeneration in adult MRL mice. ( Bedelbaeva, K; Heber-Katz, E; Lankford, EB; Leferovich, JM; Samulewicz, S; Zhang, XM; Zwas, D, 2001) |
| "The hydroxyproline/proline ratio was increased by 64% in MI-control and reduced to the sham value in MI-FG041 rats." | 1.31 | Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction. ( Bean, M; Brenner, MC; Buttrick, PM; Geenen, D; Huang, X; Nwogu, JI, 2001) |
| "Captopril and losartan treatments were equally efficient to attenuate these parameters in both ventricles." | 1.30 | [Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling]. ( Busatto, VC; de Moraes, AC; Gomes, Mda G; Milanez, Mda C; Mill, JG, 1997) |
| "Ischemic mitral regurgitation or ventricular wall motion abnormalities will alter the stress distribution in the mitral valve." | 1.30 | Altered collagen concentration in mitral valve leaflets: biochemical and finite element analysis. ( Cochran, RP; Kunzelman, KS; Quick, DW, 1998) |
| "Hydroxyproline levels were determined." | 1.30 | Reduced injury and scar in acute myocardial infarctions treated with human growth hormone. ( Castagnino, HE; Hamamura, S; Jörg, ME; Laguens, RP, 1998) |
| "Hydroxyproline contents were significantly increased in the noninfarcted septum." | 1.29 | Collagen remodeling after myocardial infarction in the rat heart. ( Cleutjens, JP; Daemen, MJ; Smiths, JF; Verluyten, MJ, 1995) |
| "The hydroxyproline assay was used to determine collagen and elastin content biochemically." | 1.29 | Peripheral vascular alterations during experimental heart failure in the rat. Do they exist? ( Aarts, PJ; Arends, JW; Daemen, MJ; Heeneman, S; Leenders, PJ; Smits, JF, 1995) |
| "The ratios of the scar thickness to normal wall thickness were superoxide dismutase 0." | 1.27 | Superoxide dismutase does not cause scar thinning after myocardial infarction. ( Abrams, GD; Buda, AJ; Lucchesi, BR; Phan, S; Pitt, B; Shea, MJ; Vaporciyan, A; Werns, SW, 1987) |
| "The nonreperfused scars had a higher proportion of fibrous tissue (73 +/- 3%) by histological evaluation and a 35% higher hydroxyproline content (31 +/- 2 mg/g dry weight, P less than 0." | 1.27 | Effects of reperfusion after coronary artery occlusion on post-infarction scar tissue. ( Apstein, CS; Bing, OH; Connelly, CM; Dunn-Lanchantin, DM; Franzblau, C; Kloner, RA; Osmers, EL; Vogel, WM; Wiegner, AW, 1985) |
| "The healing of myocardial infarction is accompanied by an increased accumulation of collagen in the heart muscle." | 1.26 | Collagen metabolism in patients with myocardial infarction. ( Cerazy, B; Drózdz, M; Jendryczko, A; Kucharz, E, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 42 (44.21) | 18.7374 |
| 1990's | 18 (18.95) | 18.2507 |
| 2000's | 20 (21.05) | 29.6817 |
| 2010's | 14 (14.74) | 24.3611 |
| 2020's | 1 (1.05) | 2.80 |
| Authors | Studies |
|---|---|
| Daud, E | 1 |
| Ertracht, O | 1 |
| Bandel, N | 1 |
| Moady, G | 1 |
| Shehadeh, M | 1 |
| Reuveni, T | 1 |
| Atar, S | 1 |
| Zhang, S | 1 |
| Cui, R | 1 |
| Godugu, C | 1 |
| Kumari, P | 1 |
| Khurana, A | 1 |
| Minicucci, MF | 2 |
| dos Santos, PP | 1 |
| Rafacho, BP | 2 |
| Gonçalves, AF | 2 |
| Silva, RA | 1 |
| Chiuso-Minicucci, F | 1 |
| Azevedo, PS | 2 |
| Polegato, BF | 2 |
| Okoshi, K | 2 |
| Pereira, EJ | 2 |
| Paiva, SA | 4 |
| Zornoff, LA | 4 |
| Santos, PP | 1 |
| Ardisson, LP | 1 |
| Batista, DF | 1 |
| Lu, Y | 1 |
| Liu, JJ | 1 |
| Bi, XY | 1 |
| Yu, XJ | 1 |
| Kong, SS | 1 |
| Qin, FF | 1 |
| Zhou, J | 1 |
| Zang, WJ | 1 |
| Zhou, HM | 1 |
| Zhong, ML | 1 |
| Zhang, YF | 1 |
| Cui, WY | 1 |
| Long, CL | 1 |
| Wang, H | 2 |
| Gao, Y | 2 |
| Gao, J | 1 |
| Chen, C | 1 |
| Guo, J | 1 |
| Wu, R | 1 |
| Li, C | 1 |
| Han, R | 1 |
| Kang, L | 1 |
| Wang, J | 1 |
| Li, Y | 1 |
| He, J | 1 |
| Tian, J | 1 |
| Chen, CY | 1 |
| Lee, BC | 1 |
| Hsu, HC | 1 |
| Lin, HJ | 1 |
| Chao, CL | 1 |
| Lin, YH | 1 |
| Ho, YL | 1 |
| Chen, MF | 1 |
| Sun, T | 1 |
| Shen, LH | 1 |
| Chen, H | 1 |
| Li, HW | 1 |
| Guo, CY | 1 |
| Li, ZZ | 1 |
| Tang, CS | 1 |
| French, CJ | 1 |
| Zaman, AK | 1 |
| Sobel, BE | 2 |
| Gu, WL | 1 |
| Chen, CX | 2 |
| Wu, Q | 1 |
| Lü, J | 1 |
| Liu, Y | 2 |
| Zhang, SJ | 1 |
| Kim, LB | 1 |
| Putiatina, AN | 1 |
| Tang, XL | 1 |
| Sanganalmath, SK | 1 |
| Sato, H | 1 |
| Bi, Q | 1 |
| Hunt, G | 1 |
| Vincent, RJ | 1 |
| Peng, Y | 1 |
| Shirk, G | 1 |
| Dawn, B | 1 |
| Bolli, R | 2 |
| Huang, XY | 1 |
| Zhang, XM | 2 |
| Wu, XM | 1 |
| Li, YM | 1 |
| Yengo, CM | 1 |
| Zimmerman, SD | 1 |
| McCormick, RJ | 1 |
| Thomas, DP | 1 |
| Yuan, QY | 1 |
| Huang, J | 1 |
| Chu, BC | 1 |
| Li, XJ | 1 |
| Li, XS | 1 |
| Si, LY | 1 |
| Cittadini, A | 1 |
| Casaburi, C | 1 |
| Monti, MG | 1 |
| Di Gianni, A | 1 |
| Serpico, R | 1 |
| Scherillo, G | 1 |
| Saldamarco, L | 1 |
| Vanasia, M | 1 |
| Saccà, L | 1 |
| Itter, G | 1 |
| Jung, W | 1 |
| Juretschke, P | 1 |
| Schoelkens, BA | 1 |
| Linz, W | 1 |
| Cavasin, MA | 1 |
| Tao, Z | 1 |
| Menon, S | 1 |
| Yang, XP | 1 |
| Jayasankar, V | 1 |
| Woo, YJ | 1 |
| Bish, LT | 1 |
| Pirolli, TJ | 1 |
| Berry, MF | 1 |
| Burdick, J | 1 |
| Bhalla, RC | 1 |
| Sharma, RV | 1 |
| Gardner, TJ | 1 |
| Sweeney, HL | 1 |
| Camp, TM | 1 |
| Tyagi, SC | 2 |
| Aru, GM | 1 |
| Hayden, MR | 1 |
| Mehta, JL | 1 |
| Yndestad, A | 1 |
| Vinge, LE | 1 |
| Bjørnerheim, R | 1 |
| Ueland, T | 1 |
| Wang, JE | 1 |
| Frøland, SS | 1 |
| Attramadal, H | 1 |
| Aukrust, P | 1 |
| Oie, E | 1 |
| Du, XJ | 1 |
| Gao, XM | 1 |
| Kiriazis, H | 1 |
| Moore, XL | 1 |
| Ming, Z | 1 |
| Su, Y | 1 |
| Finch, AM | 1 |
| Hannan, RA | 1 |
| Dart, AM | 1 |
| Graham, RM | 1 |
| Agnoletti, G | 1 |
| Cargnoni, A | 1 |
| Agnoletti, L | 1 |
| Di Marcello, M | 1 |
| Balzarini, P | 1 |
| Pasini, E | 1 |
| Gitti, G | 1 |
| Martina, P | 1 |
| Ardesi, R | 1 |
| Ferrari, R | 1 |
| Jugdutt, BI | 9 |
| Idikio, H | 3 |
| Uwiera, RR | 2 |
| Drobnik, J | 1 |
| Karbownik-Lewińska, M | 1 |
| Szczepanowska, A | 1 |
| Słotwińska, D | 1 |
| Olczak, S | 1 |
| Jakubowski, L | 1 |
| Dabrowski, R | 1 |
| Lerman, RH | 1 |
| Apstein, CS | 3 |
| Kagan, HM | 1 |
| Osmers, EL | 2 |
| Chichester, CO | 1 |
| Vogel, WM | 2 |
| Connelly, CM | 2 |
| Steffee, WP | 1 |
| Movshovich, BL | 8 |
| Mimbs, JW | 2 |
| O'Donnell, M | 2 |
| Bauwens, D | 1 |
| Miller, JW | 1 |
| Chiariello, M | 2 |
| Brevetti, G | 1 |
| Ambrosio, G | 2 |
| Cataffo, A | 1 |
| Pollice, U | 1 |
| Condorelli, M | 1 |
| Roberts, CS | 1 |
| Schoen, FJ | 6 |
| Kloner, RA | 7 |
| Nikitin, JP | 1 |
| Korobkowa, HN | 1 |
| Hammerman, H | 5 |
| Braunwald, E | 5 |
| Brown, EJ | 2 |
| Hale, S | 3 |
| Kucharz, E | 1 |
| Drózdz, M | 1 |
| Cerazy, B | 1 |
| Jendryczko, A | 1 |
| Miller, JG | 1 |
| Cleutjens, JP | 1 |
| Verluyten, MJ | 1 |
| Smiths, JF | 1 |
| Daemen, MJ | 2 |
| Heeneman, S | 1 |
| Leenders, PJ | 1 |
| Aarts, PJ | 1 |
| Smits, JF | 1 |
| Arends, JW | 1 |
| Gupta, KB | 1 |
| Ratcliffe, MB | 1 |
| Fallert, MA | 1 |
| Edmunds, LH | 1 |
| Bogen, DK | 1 |
| Sanbe, A | 1 |
| Tanonaka, K | 1 |
| Hanaoka, Y | 1 |
| Katoh, T | 1 |
| Takeo, S | 1 |
| Wiggers, H | 1 |
| Klebe, T | 1 |
| Heickendorff, L | 1 |
| Høst, NB | 1 |
| Danielsen, CC | 1 |
| Baandrup, U | 1 |
| Andersen, HR | 1 |
| Jonderko, G | 1 |
| Kucharz, EJ | 1 |
| Fink, M | 1 |
| Filipek, B | 1 |
| Kotrys-Puchalska, E | 1 |
| Wedrychowska, A | 1 |
| Lucas, A | 1 |
| Khan, MI | 2 |
| Ju, H | 1 |
| Zhao, S | 1 |
| Jassal, DS | 1 |
| Dixon, IM | 1 |
| McDonald, K | 1 |
| Chu, C | 1 |
| Francis, G | 1 |
| Judd, D | 1 |
| Carlyle, W | 1 |
| Toher, C | 1 |
| Hauer, K | 1 |
| Hartman, M | 1 |
| Mill, JG | 1 |
| Milanez, Mda C | 1 |
| Busatto, VC | 1 |
| de Moraes, AC | 1 |
| Gomes, Mda G | 1 |
| Kunzelman, KS | 1 |
| Quick, DW | 1 |
| Cochran, RP | 1 |
| Laguens, RP | 1 |
| Castagnino, HE | 1 |
| Jörg, ME | 1 |
| Hamamura, S | 1 |
| Matsubara, BB | 2 |
| Matsubara, LS | 2 |
| Tornero, MT | 1 |
| Spadaro, J | 2 |
| Wei, S | 1 |
| Chow, LT | 1 |
| Sanderson, JE | 1 |
| Podesser, BK | 1 |
| Siwik, DA | 1 |
| Eberli, FR | 1 |
| Sam, F | 1 |
| Ngoy, S | 1 |
| Lambert, J | 1 |
| Ngo, K | 1 |
| Colucci, WS | 1 |
| Leferovich, JM | 1 |
| Bedelbaeva, K | 1 |
| Samulewicz, S | 1 |
| Zwas, D | 1 |
| Lankford, EB | 1 |
| Heber-Katz, E | 1 |
| Nwogu, JI | 1 |
| Geenen, D | 1 |
| Bean, M | 1 |
| Brenner, MC | 1 |
| Huang, X | 1 |
| Buttrick, PM | 1 |
| Menon, V | 1 |
| Kumar, D | 1 |
| Naddachina, TA | 1 |
| Vinogradov, AV | 1 |
| Panormov, VV | 1 |
| Takahashi, S | 1 |
| Judd, JT | 2 |
| Wexler, BC | 2 |
| Litwin, SE | 1 |
| Raya, TE | 1 |
| Warner, A | 1 |
| Litwin, CM | 1 |
| Goldman, S | 1 |
| Ravichandran, LV | 1 |
| Puvanakrishnan, R | 1 |
| Scholz, TD | 1 |
| Vandenberg, BF | 1 |
| Fleagle, SR | 1 |
| Collins, SM | 2 |
| Kerber, RE | 1 |
| Skorton, DJ | 2 |
| Virmani, R | 1 |
| Osmialowski, AF | 1 |
| Kolodgie, FD | 1 |
| Forman, MB | 1 |
| Barmotin, GV | 2 |
| Kinoshenko, EI | 1 |
| Aliavi, AL | 1 |
| Vlasenko, MA | 1 |
| Kaliabin, GA | 1 |
| Greĭskop, IA | 1 |
| Sekita, S | 1 |
| Katagiri, T | 1 |
| Sasai, Y | 1 |
| Takeda, K | 1 |
| Cappelli-Bigazzi, M | 1 |
| Perrone-Filardi, P | 1 |
| Brigante, F | 1 |
| Sifola, C | 1 |
| Shimazu, T | 1 |
| Nishioka, H | 1 |
| Fujiwara, M | 1 |
| Matsuyama, T | 1 |
| Ozaki, H | 1 |
| Hamanaka, Y | 1 |
| Kitabatake, A | 1 |
| Inoue, M | 1 |
| Kamada, T | 1 |
| Matsumoto, M | 1 |
| Werns, SW | 1 |
| Shea, MJ | 1 |
| Vaporciyan, A | 1 |
| Phan, S | 1 |
| Abrams, GD | 1 |
| Buda, AJ | 1 |
| Pitt, B | 1 |
| Lucchesi, BR | 1 |
| Leshchinskii, LA | 1 |
| Vtorov, AE | 1 |
| Hoyt, RH | 1 |
| Ericksen, EE | 1 |
| Conyers, D | 1 |
| Amy, RW | 1 |
| Alker, KJ | 1 |
| Cannon, RO | 1 |
| Rodríguez, ER | 1 |
| Speir, E | 1 |
| Yamaguchi, M | 1 |
| Butany, J | 1 |
| McManus, BM | 1 |
| Ferrans, VJ | 1 |
| Wiegner, AW | 1 |
| Bing, OH | 1 |
| Dunn-Lanchantin, DM | 1 |
| Franzblau, C | 1 |
| Rupniewska, ZM | 4 |
| Widomska-Czekajska, T | 4 |
| Miturzyńska-Stryjecka, H | 4 |
| Bielak, Z | 4 |
| Mishurova, VP | 1 |
| Gudbjarnason, S | 1 |
| Puri, PS | 1 |
| Mathes, P | 1 |
| Ino, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Study of Pirfenidone in the Treatment of Myocardial Fibrosis After Acute Myocardial Infarction: a Phase II Prospective, Randomized, Double-blind，Placebo Controlled Clinical Trial[NCT05531955] | Phase 2 | 100 participants (Anticipated) | Interventional | 2022-08-05 | Active, not recruiting | ||
| Efficacy and Safety of an Early Phase Single Bolus r-SAK for Acute Myocardial Infarction: a Multi-center Randomized Clinical Trial (OPTIMA-5)[NCT05023681] | Phase 4 | 200 participants (Actual) | Interventional | 2021-10-29 | Completed | ||
| A Single Bolus r-SAK Prior to Primary PCI for ST-elevation Myocardial Infarction (OPTIMA-5): 1-Year Follow-up[NCT05649696] | Phase 4 | 210 participants (Actual) | Interventional | 2021-10-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for hydroxyproline and Cardiovascular Stroke
| Article | Year |
|---|---|
[Effect of heart infarction on levels of type I procollagen carboxyterminal peptide in blood serum].
Topics: Adult; Aged; Aspartate Aminotransferases; Creatine Kinase; Electrocardiography; Female; Humans; Hydr | 1996 |
94 other studies available for hydroxyproline and Cardiovascular Stroke
| Article | Year |
|---|---|
The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats.
Topics: Animals; Benzhydryl Compounds; Collagen; Disease Models, Animal; Fibrosis; Glucosides; Hydroxyprolin | 2021 |
The targeted regulation of miR-26a on PTEN-PI3K/AKT signaling pathway in myocardial fibrosis after myocardial infarction.
Topics: Animals; Antagomirs; Cell Differentiation; Disease Models, Animal; Fibroblasts; Hydroxyproline; Male | 2018 |
Nanoyttria attenuates isoproterenol-induced cardiac injury.
Topics: Animals; Cardiotoxicity; Cytokines; Gene Expression Regulation; Heart; Heart Injuries; Hydroxyprolin | 2018 |
Mechanisms involved in the beneficial effects of spironolactone after myocardial infarction.
Topics: Analysis of Variance; Animals; Blotting, Western; Body Weights and Measures; Collagen; Echocardiogra | 2013 |
Periostin as a modulator of chronic cardiac remodeling after myocardial infarction.
Topics: Animals; Blotting, Western; Cell Adhesion Molecules; Collagen Type I; Collagen Type III; Diastole; D | 2013 |
Pyridostigmine ameliorates cardiac remodeling induced by myocardial infarction via inhibition of the transforming growth factor-β1/TGF-β1-activated kinase pathway.
Topics: Animals; Cholinesterase Inhibitors; Fibrosis; Hemodynamics; Hydroxyproline; Male; MAP Kinase Kinase | 2014 |
Natakalim improves post-infarction left ventricular remodeling by restoring the coordinated balance between endothelial function and cardiac hypertrophy.
Topics: Administration, Oral; Allyl Compounds; Animals; Blood Pressure; Cardiomegaly; Dose-Response Relation | 2014 |
Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
Topics: Aldosterone; Animals; Antioxidants; Captopril; Collagen; Coronary Occlusion; Coronary Vessels; Endot | 2015 |
Pirfenidone controls the feedback loop of the AT1R/p38 MAPK/renin-angiotensin system axis by regulating liver X receptor-α in myocardial infarction-induced cardiac fibrosis.
Topics: Angiotensin II; Animals; Cardiomegaly; Collagen Type I; Collagen Type III; Feedback, Physiological; | 2017 |
A proteomic study of the effects of ramipril on post-infarction left ventricular remodelling in the rabbit.
Topics: Animals; Blotting, Western; Catalase; Cyclophilin A; Down-Regulation; Echocardiography; Electrophore | 2008 |
[Effects of carvedilol and metoprolol on cardiac fibrosis in rats with experimental myocardial infarction].
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Collagen; Disease Models, Animal; Fibr | 2008 |
Cardiac fibrosis and diastolic dysfunction after myocardial infarction in apolipoprotein E knockout mice.
Topics: Animals; Apolipoproteins E; Body Weight; Diastole; Disease Models, Animal; Echocardiography, Doppler | 2009 |
Effects of Chinese herb medicine Radix Scrophulariae on ventricular remodeling.
Topics: Angiotensin II; Animals; Collagen; Coronary Vessels; Hydroxyproline; Ligation; Male; Myocardial Infa | 2010 |
[Dynamics of biochemical markers of reparative fibrosis in uncomplicated course of myocardial infarction].
Topics: Adult; Aged; Biomarkers; Disease Progression; Echocardiography; Electrocardiography; Female; Fibrone | 2010 |
Atorvastatin therapy during the peri-infarct period attenuates left ventricular dysfunction and remodeling after myocardial infarction.
Topics: Animals; Apoptosis; Atorvastatin; Female; Heptanoic Acids; Hydroxymethylglutaryl-CoA Reductase Inhib | 2011 |
Effects of ethanolic extract from Radix Scrophulariae on ventricular remodeling in rats.
Topics: Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Chemical Analysis; Captopril; Cardiomegaly | 2012 |
Exercise training post-MI favorably modifies heart extracellular matrix in the rat.
Topics: Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Collagen; Disease Models, Anima | 2012 |
A targeted high-efficiency angiogenesis strategy as therapy for myocardial infarction.
Topics: Animals; Coronary Vessels; Dogs; Genetic Therapy; Human Growth Hormone; Humans; Hydroxyproline; Male | 2012 |
Effects of canrenone on myocardial reactive fibrosis in a rat model of postinfarction heart failure.
Topics: Administration, Oral; Aldosterone; Animals; Canrenone; Collagen; Cyclodextrins; Disease Models, Anim | 2002 |
A model of chronic heart failure in spontaneous hypertensive rats (SHR).
Topics: Animals; Aorta; Blood Pressure; Disease Models, Animal; Heart Failure; Heart Rate; Hydroxyproline; H | 2004 |
Gender differences in cardiac function during early remodeling after acute myocardial infarction in mice.
Topics: Acute Disease; Animals; Blood Pressure; Body Weight; Chronic Disease; Collagen; Female; Heart; Heart | 2004 |
Inhibition of matrix metalloproteinase activity by TIMP-1 gene transfer effectively treats ischemic cardiomyopathy.
Topics: Adenoviridae; Animals; Defective Viruses; Drug Evaluation, Preclinical; Fibrosis; Genes, Synthetic; | 2004 |
Doxycycline ameliorates ischemic and border-zone remodeling and endothelial dysfunction after myocardial infarction in rats.
Topics: Animals; Cardiotonic Agents; Doxycycline; Endocardium; Hydroxyproline; Matrix Metalloproteinase 2; M | 2004 |
Thalidomide attenuates the development of fibrosis during post-infarction myocardial remodelling in rats.
Topics: Animals; Blood Pressure; Cytokines; Disease Models, Animal; Fibrosis; Gene Expression; Hydroxyprolin | 2006 |
Transgenic alpha1A-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival.
Topics: Actins; Aging; Animals; Atrial Natriuretic Factor; Collagen; Echocardiography; Female; Fibronectins; | 2006 |
Experimental ischemic cardiomyopathy: insights into remodeling, physiological adaptation, and humoral response.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Echocardiography, Doppler; Heart R | 2006 |
Experimental ischemic cardiomyopathy: insights into remodeling, physiological adaptation, and humoral response.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Echocardiography, Doppler; Heart R | 2006 |
Experimental ischemic cardiomyopathy: insights into remodeling, physiological adaptation, and humoral response.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Echocardiography, Doppler; Heart R | 2006 |
Experimental ischemic cardiomyopathy: insights into remodeling, physiological adaptation, and humoral response.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiomyopathy, Dilated; Echocardiography, Doppler; Heart R | 2006 |
Angiotensin receptor blockade and angiotensin-converting-enzyme inhibition limit adverse remodeling of infarct zone collagens and global diastolic dysfunction during healing after reperfused ST-elevation myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting En | 2007 |
Therapeutic drugs during healing after myocardial infarction modify infarct collagens and ventricular distensibility at elevated pressures.
Topics: Animals; Blood Pressure; Collagen; Dogs; Drug-Related Side Effects and Adverse Reactions; Hydroxypro | 2007 |
Regulatory influence of melatonin on collagen accumulation in the infarcted heart scar.
Topics: Animals; Cells, Cultured; Cicatrix; Collagen; Fibroblasts; Gene Expression Regulation; Hydroxyprolin | 2008 |
Myocardial healing and repair after experimental infarction in the rabbit.
Topics: Animals; Collagen; Coronary Vessels; Hydroxyproline; Ligation; Male; Myocardial Infarction; Procolla | 1983 |
[Myocardial repair in infarction: parallels of clinico-laboratory indices, morphology and biochemistry of infarcted myocardium].
Topics: Adult; Aged; Blood Sedimentation; Female; Fibrinogen; Glycosaminoglycans; Humans; Hydroxyproline; Le | 1982 |
The dependence of ultrasonic attenuation and backscatter on collagen content in dog and rabbit hearts.
Topics: Animals; Arterial Occlusive Diseases; Buffers; Collagen; Coronary Vessels; Dogs; Hydroxyproline; Mic | 1980 |
Long-term protection of ischaemic myocardium by nitroglycerin ointment.
Topics: Animals; Collagen; Creatine Kinase; Hydroxyproline; Male; Myocardial Infarction; Myocardium; Necrosi | 1984 |
Effect of coronary reperfusion on myocardial hemorrhage and infarct healing.
Topics: Animals; Coronary Circulation; Coronary Vessels; Creatine Kinase; Dogs; Female; Hemoglobins; Hydroxy | 1983 |
[Hydroxyproline in blood and urine in myocardial infarct].
Topics: Adolescent; Adult; Age Factors; Child; Child, Preschool; Humans; Hydroxyproline; Male; Middle Aged; | 1983 |
Drug-induced expansion of infarct: morphologic and functional correlations.
Topics: Animals; Dogs; Echocardiography; Female; Heart Ventricles; Hydroxyproline; Indomethacin; Male; Myoca | 1984 |
Scar thinning due to ibuprofen administration after experimental myocardial infarction.
Topics: Animals; Aspirin; Dogs; Female; Hydroxyproline; Ibuprofen; Male; Myocardial Infarction; Myocardium | 1983 |
Indomethacin-induced scar thinning after experimental myocardial infarction.
Topics: Animals; Dogs; Female; Hydroxyproline; Indomethacin; Male; Myocardial Infarction; Myocardium | 1983 |
Dose-dependent effects of short-term methylprednisolone on myocardial infarct extent, scar formation, and ventricular function.
Topics: Animals; Cicatrix; Dogs; Dose-Response Relationship, Drug; Echocardiography; Female; Heart Ventricle | 1983 |
Collagen metabolism in patients with myocardial infarction.
Topics: Adult; Aged; Blood Proteins; Carrier Proteins; Collagen; Humans; Hydroxylysine; Hydroxyproline; Midd | 1982 |
Relationship between collagen and ultrasonic backscatter in myocardial tissue.
Topics: Animals; Collagen; Dogs; Hydroxyproline; Myocardial Infarction; Myocardium; Ultrasonics | 1981 |
Collagen remodeling after myocardial infarction in the rat heart.
Topics: Animals; Blotting, Northern; Collagen; Heart; Hydroxyproline; Immunohistochemistry; In Situ Hybridiz | 1995 |
Peripheral vascular alterations during experimental heart failure in the rat. Do they exist?
Topics: Animals; Aorta, Abdominal; Aorta, Thoracic; Blood Flow Velocity; Blood Vessels; Cardiac Output, Low; | 1995 |
Changes in passive mechanical stiffness of myocardial tissue with aneurysm formation.
Topics: Animals; Elasticity; Heart; Heart Aneurysm; Hydroxyproline; Myocardial Contraction; Myocardial Infar | 1994 |
Regional energy metabolism of failing hearts following myocardial infarction.
Topics: Acute Disease; Animals; Energy Metabolism; Heart; Hemodynamics; Hydroxyproline; Myocardial Infarctio | 1993 |
Ischemia and reperfusion of the porcine myocardium: effect on collagen.
Topics: Analysis of Variance; Animals; Biomarkers; Collagen; Collagen Type I; Creatine Kinase; Disease Model | 1997 |
Effect of angiotensin-converting enzyme inhibition on infarct collagen deposition and remodelling during healing after transmural canine myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Collagen; Dogs; Enalapril; Heart Ventr | 1997 |
Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biomarkers; Blot | 1997 |
The effect of delayed reperfusion following infarction in the rat on structural changes in viable myocardium.
Topics: Animals; Cell Nucleus; Cell Size; Hydroxyproline; Hypertrophy, Left Ventricular; Microscopy, Confoca | 1997 |
[Activation of the cardiac angiotensin-converting enzyme after myocardial infarction and its role in ventricular remodeling].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Captopri | 1997 |
Altered collagen concentration in mitral valve leaflets: biochemical and finite element analysis.
Topics: Animals; Biochemical Phenomena; Biochemistry; Chordae Tendineae; Collagen; Elasticity; Finite Elemen | 1998 |
Reduced injury and scar in acute myocardial infarctions treated with human growth hormone.
Topics: Animals; Growth Hormone; Humans; Hydroxyproline; Male; Myocardial Infarction; Myocardium; Rats; Rats | 1998 |
Effects of lisinopril on experimental ischemia in rats. Influence of infarct size.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiomegaly; Fibrosis; Hydroxyproline; Lisinopri | 1999 |
Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Carbazoles; Carvedil | 2000 |
Effects of losartan on ventricular remodeling in experimental infarction in rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Case-Control Studies; Hydroxyproline; Losartan; Ma | 2000 |
ET(A)-receptor blockade prevents matrix metalloproteinase activation late postmyocardial infarction in the rat.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Calcium-Transporting ATPases; Endothelin Recepto | 2001 |
Heart regeneration in adult MRL mice.
Topics: Animals; Biomarkers; Cicatrix; Cold Temperature; Collagen; Collagen Type I; Collagen Type I, alpha 1 | 2001 |
Inhibition of collagen synthesis with prolyl 4-hydroxylase inhibitor improves left ventricular function and alters the pattern of left ventricular dilatation after myocardial infarction.
Topics: Animals; Collagen; Dilatation, Pathologic; Disease Models, Animal; Echocardiography; Enzyme Inhibito | 2001 |
Vascular remodeling during healing after myocardial infarction in the dog model: effects of reperfusion, amlodipine and enalapril.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Calcium Channel Blockers; | 2002 |
[Myocardial infarct repair in the light of clinico-biochemical and morphological studies].
Topics: Adult; Aged; alpha-Macroglobulins; Asparagine; Creatine Kinase; Erythrocyte Count; Female; Fibrinoge | 1977 |
[Clinico-biochemical principles of healing of myocardial infarct].
Topics: Adult; Aged; alpha-Macroglobulins; Erythrocyte Count; Female; Glycoproteins; Humans; Hydroxyproline; | 1979 |
A study on myocardial fibrosis in myocardial infarction and in idiopathic cardiomyopathy: a measurement of hydroxyproline level in plasma and in myocardium.
Topics: Animals; Cardiomyopathies; Dogs; Endomyocardial Fibrosis; Humans; Hydroxyproline; Myocardial Infarct | 1979 |
Prolyl hydroxylase and collagen metabolism after experimental mycardial infarction.
Topics: Animals; Collagen; Hydroxyproline; Isoproterenol; Male; Mixed Function Oxygenases; Myocardial Infarc | 1975 |
Impact of increased infarct transmurality on remodeling and function during healing after anterior myocardial infarction in the dog.
Topics: Animals; Collagen; Coronary Circulation; Coronary Vessels; Dogs; Echocardiography; Electrocardiograp | 1992 |
Effects of captopril on contractility after myocardial infarction: experimental observations.
Topics: Animals; Blood Pressure; Blood Volume; Captopril; Cardiac Output, Low; Collagen; Hydroxyproline; Iso | 1991 |
In vivo labeling studies on the biosynthesis and degradation of collagen in experimental myocardial infarction.
Topics: Animals; Collagen; Female; Hydroxyproline; Isoproterenol; Myocardial Infarction; Proline; Radioactiv | 1991 |
Tissue characterization of chronic myocardial infarction.
Topics: Animals; Chronic Disease; Dogs; Echocardiography; Hydroxyproline; Magnetic Resonance Imaging; Myocar | 1990 |
The effect of perfluorochemical fluosol-DA (20%) on myocardial infarct healing in the rabbit.
Topics: Analysis of Variance; Animals; Disease Models, Animal; Drug Combinations; Fluorocarbons; Foam Cells; | 1990 |
[The diagnosis and reparative processes in a protracted course of myocardial infarct].
Topics: Aged; Coronary Disease; Electrocardiography; Female; Hexoses; Humans; Hydroxyproline; Male; Middle A | 1989 |
[Thrombocyte function and the repair of myocardial infarct].
Topics: Aspirin; Blood Platelets; Dipyridamole; Female; Heart Function Tests; Humans; Hydroxyproline; Male; | 1989 |
[Clinical regularities of myocardial infarction repair].
Topics: Glycoproteins; Hexoses; Humans; Hydroxyproline; Mucoproteins; Myocardial Infarction; Regeneration; R | 1989 |
[Clinico-biochemical equivalent of stromal destruction in acute myocardial infarction].
Topics: Collagen; Connective Tissue; Hexoses; Humans; Hydroxybutyrate Dehydrogenase; Hydroxyproline; Myocard | 1989 |
Studies on collagen in the experimental myocardial infarction.
Topics: Animals; Cell Movement; Collagen; Dogs; Fibroblasts; Hydroxyproline; Myocardial Infarction; Myocardi | 1985 |
A biochemical method for the quantitation of myocardial scarring after experimental coronary artery occlusion.
Topics: Animals; Arteries; Chloramines; Collagen; Coronary Vessels; Disease Models, Animal; Heart Ventricles | 1986 |
Effect of nitroglycerin and ibuprofen on left ventricular topography and rupture threshold during healing after myocardial infarction in the dog.
Topics: Animals; Dogs; Echocardiography; Heart; Heart Rupture; Hemodynamics; Hydroxyproline; Ibuprofen; Myoc | 1988 |
[Quantitative integrated backscatter characteristics in the normal and infarcted canine myocardium].
Topics: Animals; Dogs; Hydroxyproline; Monitoring, Physiologic; Myocardial Infarction; Myocardium; Ultrasono | 1986 |
Superoxide dismutase does not cause scar thinning after myocardial infarction.
Topics: Animals; Cicatrix; Dogs; Echocardiography; Granulation Tissue; Hydroxyproline; Male; Myocardial Infa | 1987 |
Left ventricular rupture threshold during the healing phase after myocardial infarction in the dog.
Topics: Animals; Coronary Vessels; Dogs; Heart Diseases; Heart Ventricles; Hemodynamics; Hydroxyproline; Lig | 1987 |
The dynamics of healing processes in the heart muscle in acute myocardial infarction.
Topics: Adult; Aged; Cicatrix; Collagen; Female; Humans; Hydroxyproline; Male; Middle Aged; Myocardial Infar | 1987 |
Assessment of fibrosis in infarcted human hearts by analysis of ultrasonic backscatter.
Topics: Collagen; Humans; Hydroxyproline; Myocardial Infarction; Tissue Distribution; Ultrasonography | 1985 |
Delayed effects of early infarct-limiting therapies on healing after myocardial infarction.
Topics: Animals; Collagen; Dogs; Epoprostenol; Hemodynamics; Hydroxyproline; Ibuprofen; Macrophages; Myocard | 1985 |
Healing after myocardial infarction in the dog: changes in infarct hydroxyproline and topography.
Topics: Animals; Arterial Occlusive Diseases; Cicatrix; Dilatation, Pathologic; Dogs; Hydroxyproline; Myocar | 1986 |
Effects of transient increased afterload during experimentally induced acute myocardial infarction in dogs.
Topics: Animals; Dogs; Heart Ventricles; Hydroxyproline; Hypertension; Methoxamine; Myocardial Infarction; R | 1985 |
Effect of ibuprofen on the healing phase of experimental myocardial infarction in the rat.
Topics: Animals; Cell Count; Collagen; Hydroxyproline; Ibuprofen; Leukocytes; Male; Myocardial Infarction; R | 1985 |
Effects of reperfusion after coronary artery occlusion on post-infarction scar tissue.
Topics: Animals; Arteries; Cicatrix; Collagen; Coronary Vessels; Desmosine; Elastin; Hydroxyproline; Ligatio | 1985 |
[Urinary excretion of acid mucopolysaccharides and total hydroxyproline in myocardial infarction].
Topics: Adult; Aged; Female; Glycosaminoglycans; Humans; Hydroxyproline; Male; Middle Aged; Myocardial Infar | 1968 |
Myocardial connective tissue metabolism in response to injury. Histological and chemical studies of mucopolysaccharide and collagen in rat hearts after isoproterenol-induced infaraction.
Topics: Animals; Arteriosclerosis; Cicatrix; Collagen; Connective Tissue; Female; Glycosaminoglycans; Hexosa | 1969 |
Urinary elimination of acid mucopolysaccharides and total hydroxyproline in myocardial infarction.
Topics: Adult; Aged; Female; Glycosaminoglycans; Humans; Hydroxyproline; Male; Middle Aged; Myocardial Infar | 1969 |
[Early and late diagnostic biochemical indices in myocardial infarct].
Topics: Arteriosclerosis; Clinical Enzyme Tests; Collagen; Coronary Disease; Creatine Kinase; Haptoglobins; | 1974 |
[Basic indices of collagen metabolism in ischemic heart disease].
Topics: Arteriosclerosis; Collagen; Coronary Disease; Humans; Hydroxyproline; Myocardial Infarction; Necrosi | 1972 |
Biochemical changes in non-infarcted heart muscle following myocardial infarction.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Biopsy; Carbon Isotopes; Coronary Vessels; D | 1971 |
Study on the idiopathic cardiomyopathy. Diagnostic value of the apexcardiogram, 131 Cs scintiscanning of the heart and plasma hydroxyproline.
Topics: Adult; Amyl Nitrite; Autopsy; Cardiomyopathies; Cesium Isotopes; Child; Collagen; Collagen Diseases; | 1971 |
Hydroxyproline in myocardial infarction and angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Female; Humans; Hydroxyproline; Male; Middle Aged; Myocardial Infarcti | 1968 |
Hydroxyproline in myocardial infarction and angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Female; Humans; Hydroxyproline; Male; Methods; Middle Aged; Myocardial | 1969 |